Dapagliflozin in Active Lupus Nephritis

Clinical trial NCT07323524 · RECRUITING

Trial details

NCT number: NCT07323524
Sponsor: Brigham and Women's Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Lupus Nephritis (LN)

Start date: 2026-05-19
Primary completion: 2029-07-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.